BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11167040)

  • 21. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
    Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
    J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
    Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
    Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.
    Roberts HC; Roberts TP; Brasch RC; Dillon WP
    AJNR Am J Neuroradiol; 2000 May; 21(5):891-9. PubMed ID: 10815665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma assessment using quantitative blood volume maps generated by T1-weighted dynamic contrast-enhanced magnetic resonance imaging: a receiver operating characteristic study.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Acta Radiol; 2006 Apr; 47(3):303-10. PubMed ID: 16613313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
    Wu R; Watanabe Y; Arisawa A; Takahashi H; Tanaka H; Fujimoto Y; Watabe T; Isohashi K; Hatazawa J; Tomiyama N
    Jpn J Radiol; 2017 Oct; 35(10):613-621. PubMed ID: 28879406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination.
    Li X; Rooney WD; Várallyay CG; Gahramanov S; Muldoon LL; Goodman JA; Tagge IJ; Selzer AH; Pike MM; Neuwelt EA; Springer CS
    J Magn Reson; 2010 Oct; 206(2):190-9. PubMed ID: 20674422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
    Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
    Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
    Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model.
    Ostrowitzki S; Fick J; Roberts TP; Wendland MF; Aldape KD; Mann JS; Israel MA; Brasch RC
    J Magn Reson Imaging; 1998; 8(4):799-806. PubMed ID: 9702880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility.
    Aronen HJ; Glass J; Pardo FS; Belliveau JW; Gruber ML; Buchbinder BR; Gazit IE; Linggood RM; Fischman AJ; Rosen BR
    Acta Radiol; 1995 Sep; 36(5):520-8. PubMed ID: 7640098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.
    Provenzale JM; Wang GR; Brenner T; Petrella JR; Sorensen AG
    AJR Am J Roentgenol; 2002 Mar; 178(3):711-6. PubMed ID: 11856703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.
    Aprile I; Giovannelli G; Fiaschini P; Muti M; Kouleridou A; Caputo N
    Radiol Med; 2015 Oct; 120(10):967-74. PubMed ID: 25762408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.
    Sarin H; Kanevsky AS; Wu H; Sousa AA; Wilson CM; Aronova MA; Griffiths GL; Leapman RD; Vo HQ
    J Transl Med; 2009 Jun; 7():51. PubMed ID: 19549317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours.
    Haroon HA; Patankar TF; Zhu XP; Li KL; Thacker NA; Scott MJ; Jackson A
    Br J Radiol; 2007 Mar; 80(951):161-8. PubMed ID: 17303617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.
    Roberts HC; Roberts TP; Bollen AW; Ley S; Brasch RC; Dillon WP
    Acad Radiol; 2001 May; 8(5):384-91. PubMed ID: 11345268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
    Jain R; Narang J; Gutierrez J; Schultz LR; Scarpace L; Rosenblum M; Mikkelsen T; Rock JP
    Acad Radiol; 2011 Aug; 18(8):955-62. PubMed ID: 21718954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perfusion MR imaging: moving forward.
    Sorensen AG
    Radiology; 2008 Nov; 249(2):416-7. PubMed ID: 18936306
    [No Abstract]   [Full Text] [Related]  

  • 40. Application of histogram analysis for the evaluation of vascular permeability in glioma by the K2 parameter obtained with the dynamic susceptibility contrast method: Comparisons with Ktrans obtained with the dynamic contrast enhance method and cerebral blood volume.
    Taoka T; Kawai H; Nakane T; Hori S; Ochi T; Miyasaka T; Sakamoto M; Kichikawa K; Naganawa S
    Magn Reson Imaging; 2016 Sep; 34(7):896-901. PubMed ID: 27109485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.